The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
802646321 8026463 21 F 20110627 20160711 20110708 20160718 EXP PHHY2011CA58234 NOVARTIS 54.93 YR F Y 0.00000 20160718 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
802646321 8026463 1 PS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral 0.5 MG, QD Y S0006CA2 22527 .5 MG CAPSULE QD
802646321 8026463 2 SS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral 0.5 MG, QD Y 22527 .5 MG CAPSULE QD
802646321 8026463 3 SS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral UNK Y 22527 CAPSULE
802646321 8026463 4 SS ZANAFLEX TIZANIDINE HYDROCHLORIDE 1 Unknown UNK Y U 0
802646321 8026463 5 C FAMPYRA DALFAMPRIDINE 1 Unknown 10 MG, BID U 0 10 MG BID
802646321 8026463 6 C GABAPENTIN. GABAPENTIN 1 Unknown 400 MG, TID U 0 400 MG TID
802646321 8026463 7 C AMITRIPTYLENE AMITRIPTYLINE 1 Unknown 35 MG, QHS U 0 35 MG
802646321 8026463 8 C LORAZEPAM. LORAZEPAM 1 Unknown PRN U 0
802646321 8026463 9 C SATIVEX NABIXIMOLS 1 Oral PRN U 0
802646321 8026463 10 C ACTONEL RISEDRONATE SODIUM 1 Unknown 35 MG, WEEKLY U 0 35 MG /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
802646321 8026463 1 Relapsing-remitting multiple sclerosis
802646321 8026463 4 Product used for unknown indication
802646321 8026463 5 Product used for unknown indication
802646321 8026463 6 Product used for unknown indication
802646321 8026463 7 Product used for unknown indication
802646321 8026463 8 Product used for unknown indication
802646321 8026463 9 Product used for unknown indication
802646321 8026463 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
802646321 8026463 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
802646321 8026463 Blood pressure decreased
802646321 8026463 Central nervous system lesion
802646321 8026463 Contusion
802646321 8026463 Dizziness
802646321 8026463 Drug ineffective
802646321 8026463 Erythema
802646321 8026463 Fatigue
802646321 8026463 Fine motor skill dysfunction
802646321 8026463 Heart rate decreased
802646321 8026463 Hypoaesthesia
802646321 8026463 Impaired healing
802646321 8026463 Lymphocyte count decreased
802646321 8026463 Multiple sclerosis relapse
802646321 8026463 Muscular weakness
802646321 8026463 Neutrophil count decreased
802646321 8026463 Oral herpes
802646321 8026463 Skin injury
802646321 8026463 Somnolence
802646321 8026463 Visual impairment
802646321 8026463 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
802646321 8026463 1 20110627 0
802646321 8026463 2 20111201 20151102 0
802646321 8026463 3 20160510 20160604 0